“A real-world study on Clofarabine and Cytarabine combination in patients with relapsed/refractory acute myeloid leukemia”, Mediterr J Hematol Infect Dis, vol. 11, no. 1, p. e2019032, Apr. 2019, doi: 10.4084/mjhid.2019.032.